Deals
Tycoon Piramal Weighs $1 Billion Contract Pharma Sale
- Indian company works with advisers to gauge potential interest
- Piramal Pharma Solutions attracting buyout funds, U.S. suitors
This article is for subscribers only.
Indian tycoon Ajay Piramal is considering a sale of his contract pharmaceutical operations, which could fetch around $1 billion, people with knowledge of the matter said.
The billionaire’s Piramal Enterprises Ltd. is working with advisers to gauge interest in the business, known as Piramal Pharma Solutions, according to the people. It has sent out preliminary marketing materials to potential buyers, the people said, asking not to be identified because the information is private.